Synthesis and anticancer effects evaluation of 1-alkyl-3-(6-(2-methoxy-3-sulfonylaminopyridin-5-yl)benzo[d]thiazol-2-yl)urea as anticancer agents with low toxicity
Xiaoxiao Xie(Xi'an Jiaotong University), San‐Qi Zhang(Xi'an Jiaotong University), Minhang Xin(Zhejiang University), Qibing Mei(Southwest Medical University), Shemin Lu(Second Affiliated Hospital of Xi'an Jiaotong University), Juan Wang(Shanghai Institute of Pharmaceutical Industry), Huan Li(Xi'an Jiaotong University), Shuai Mao(Xi'an Jiaotong University)
Cited by 56
Related Papers
Small molecule selenium-containing compounds: Recent development and therapeutic applications
|European Journal of Medicinal Chemistry|2021|233
Review of the molecular mechanisms of Ganoderma lucidum triterpenoids: Ganoderic acids A, C2, D, F, DM, X and Y
|European Journal of Medicinal Chemistry|2019|192
The development of Bruton's tyrosine kinase (BTK) inhibitors from 2012 to 2017: A mini-review
|European Journal of Medicinal Chemistry|2018|168
Discovery of potent epidermal growth factor receptor (EGFR) degraders by proteolysis targeting chimera (PROTAC)
|European Journal of Medicinal Chemistry|2020|120
Strategies to target the Hedgehog signaling pathway for cancer therapy
|Medicinal Research Reviews|2018|108